Skip to main navigation
Skip to content
  • News
  • Careers
  • Open Positions
C4 Therapeutics C4 Therapeutics
  • About Us Expand
    • Overview
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
    • Clinical Advisory Board
    • Partnerships & Collaborations
    • Quality Policy Statement
  • Our Science Expand
    • Overview
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
    • Partnerships & Collaborations
    • Quality Policy Statement
  • Pipeline
  • Investors Expand
    • Overview
    • Press Releases
    • Events & Presentations
    • Scientific Publications
    • Stock Information
    • Analyst Coverage
    • SEC Filings
    • Corporate Governance
    • Email Alerts
    • Contact IR
    • FAQ
C4 Therapeutics

SEC Filing Details

    Investors

  • Overview
  • Press Releases
  • Events & Presentations
  • Stock Information
  • Analyst Coverage
  • SEC Filings
  • Corporate Governance
  • Email Alerts
  • Contact IR
  • FAQ
Menu

    Investors

  • Overview
  • Press Releases
  • Events & Presentations
  • Stock Information
  • Analyst Coverage
  • SEC Filings
  • Corporate Governance
  • Email Alerts
  • Contact IR
  • FAQ

SEC Filing Details

Document Details

Form
10-Q
Filing Date
Nov 10, 2021
Document Date
Sep 30, 2021
Form Description
Quarterly report which provides a continuing view of a company's financial position
Filing Group
Quarterly Filings
Company
C4 Therapeutics
Issuer
C4 Therapeutics, Inc.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
EX-101.CAL - XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
EX-101.DEF - XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE
EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
XML - XBRL INSTANCE DOCUMENT

Toolkit

Linkedin-in
Twitter
Phone

617-231-0700

Location

490 Arsenal Way, Suite 120 Watertown, MA 02472

Email

info@c4therapeutics.com

© 2023 C4 Therapeutics, Inc.
Privacy Policy       Terms of Use Agreement        Sitemap
Scroll to top
Search
  • About Us
    • Overview
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
    • Clinical Advisory Board
    • Partnerships & Collaborations
    • Quality Policy Statement
  • Our Science
    • Overview
    • Targeted Protein Degradation
    • C4T TORPEDO™ Platform
    • aTAG Open Source Program
    • Scientific Publications
  • Pipeline
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Scientific Publications
    • Stock Information
    • Analyst Coverage
    • SEC Filings
    • Corporate Governance
    • Email Alerts
    • Contact IR
    • FAQ
  • News
  • Careers
  • Open Positions

Search